22
Views
75
CrossRef citations to date
0
Altmetric
Original Article

Plasma Enteroglucagon after Jejunoileal Bypass with 3:1 or 1:3 Jejunoileal Ratio

, , , , , & show all
Pages 205-207 | Received 28 Sep 1978, Accepted 10 Oct 1978, Published online: 23 Feb 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Thomas D Aicher, Steven A Boyd, Maralee McVean & Anthony Celeste. (2010) Novel therapeutics and targets for the treatment of diabetes. Expert Review of Clinical Pharmacology 3:2, pages 209-229.
Read now
H. S. Besterman, C. N. Mallinson, R. Modigliani, N. D. Christofides, A. Pera, V. Ponti, D. L. Sarson & S. R. Bloom. (1983) Gut Hormones in Inflammatory Bowel Disease. Scandinavian Journal of Gastroenterology 18:7, pages 845-852.
Read now
K. B. Lauritsen, J. B. Lauritzen & K. C. Christensen. (1982) Gastric Inhibitory Polypeptide and Insulin Release in Response to Oral and Intravenous Glucose in Coeliac Disease. Scandinavian Journal of Gastroenterology 17:2, pages 241-245.
Read now
K. B. Lauritsen, K. C. Christensen & K. H. Stokholm. (1980) Gastric Inhibitory Polypeptide (GIP) Release and Incretin Effect after Oral Glucose in Obesity and after Jejunoileal Bypass. Scandinavian Journal of Gastroenterology 15:4, pages 489-495.
Read now

Articles from other publishers (71)

David C. D. Hope, Matthew L. Vincent & Tricia M. M. Tan. (2021) Striking the Balance: GLP-1/Glucagon Co-Agonism as a Treatment Strategy for Obesity. Frontiers in Endocrinology 12.
Crossref
Martha A. Schalla, Yvette Taché & Andreas Stengel. 2011. Comprehensive Physiology. Comprehensive Physiology 1679 1730 .
Jens J. Holst, Nicolai J. Wewer Albrechtsen, Mette M. Rosenkilde & Carolyn F. Deacon. 2011. Comprehensive Physiology. Comprehensive Physiology 1339 1381 .
Jens Juul Holst, Sten Madsbad, Kirstine N. Bojsen-Møller, Maria Saur Svane, Nils Bruun Jørgensen, Carsten Dirksen & Christoffer Martinussen. (2018) Mechanisms in bariatric surgery: Gut hormones, diabetes resolution, and weight loss. Surgery for Obesity and Related Diseases 14:5, pages 708-714.
Crossref
Jens J. Holst. (2016) Gut hormones and gastric bypass. Cardiovascular Endocrinology 5:3, pages 69-74.
Crossref
Jens Juul Holst & Sten Madsbad. (2016) Mechanisms of surgical control of type 2 diabetes: GLP-1 is key factor. Surgery for Obesity and Related Diseases 12:6, pages 1236-1242.
Crossref
Thomas A. Lutz & Marco Bueter. (2014) The physiology underlying Roux-en-Y gastric bypass: a status report. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 307:11, pages R1275-R1291.
Crossref
Alessandro Pocai. (2014) Action and therapeutic potential of oxyntomodulin. Molecular Metabolism 3:3, pages 241-251.
Crossref
Carl Frederik Hansen, Marco Bueter, Nadine Theis, Thomas Lutz, Sarah Paulsen, Louise S. Dalbøge, Niels Vrang & Jacob Jelsing. (2013) Hypertrophy Dependent Doubling of L-Cells in Roux-en-Y Gastric Bypass Operated Rats. PLoS ONE 8:6, pages e65696.
Crossref
Alessandro Pocai. (2012) Unraveling oxyntomodulin, GLP1's enigmatic brother. Journal of Endocrinology 215:3, pages 335-346.
Crossref
Joseph Varon & Ilse M. Espina. 2012. Critical Care Management of the Obese Patient. Critical Care Management of the Obese Patient 102 107 .
S. S. Torekov, S. Madsbad & J. J. Holst. (2011) Obesity - an indication for GLP-1 treatment? Obesity pathophysiology and GLP-1 treatment potential. Obesity Reviews 12:8, pages 593-601.
Crossref
C N Ochner, C Gibson, M Shanik, V Goel & A Geliebter. (2010) Changes in neurohormonal gut peptides following bariatric surgery. International Journal of Obesity 35:2, pages 153-166.
Crossref
Y-L Liu, H E Ford, M R Druce, J S Minnion, B C T Field, J C Shillito, J Baxter, K G Murphy, M A Ghatei & S R Bloom. (2010) Subcutaneous oxyntomodulin analogue administration reduces body weight in lean and obese rodents. International Journal of Obesity 34:12, pages 1715-1725.
Crossref
R T Long, W S Zeng, L Y Chen, J Guo, Y Z Lin, Q S Huang & S Q Luo. (2010) Bifidobacterium as an oral delivery carrier of oxyntomodulin for obesity therapy: inhibitory effects on food intake and body weight in overweight mice. International Journal of Obesity 34:4, pages 712-719.
Crossref
Carsten DirksenDorte L. HansenSten MadsbadLisbeth E. HvolrisLars S. NaverJens J. HolstDorte Worm. (2010) Postprandial Diabetic Glucose Tolerance Is Normalized by Gastric Bypass Feeding as Opposed to Gastric Feeding and Is Associated With Exaggerated GLP-1 Secretion. Diabetes Care 33:2, pages 375-377.
Crossref
M. Guldstrand, B. Ahrén, E. Näslund, J. J. Holst & U. Adamson. (2009) Dissociated incretin response to oral glucose at 1 year after restrictive vs. malabsorptive bariatric surgery. Diabetes, Obesity and Metabolism 11:11, pages 1027-1033.
Crossref
Gustavo Duarte Pimentel, João Felipe Mota & Lila Missae Oyama. (2009) Oxintomodulina e obesidade. Revista de Nutrição 22:5, pages 727-737.
Crossref
Hutan Ashrafian & Carel W. le Roux. (2009) Metabolic surgery and gut hormones – A review of bariatric entero-humoral modulation. Physiology & Behavior 97:5, pages 620-631.
Crossref
Channa N. Jayasena & Steve R. Bloom. (2008) Role of Gut Hormones in Obesity. Endocrinology and Metabolism Clinics of North America 37:3, pages 769-787.
Crossref
R. P. Vincent & C. W. le Roux. (2008) Changes in gut hormones after bariatric surgery. Clinical Endocrinology 69:2, pages 173-179.
Crossref
Sergei Zolotukhin. 2008. Handbook of Obesity. Handbook of Obesity 453 468 .
J. V. Gardiner, C. N. Jayasena & S. R. Bloom. (2008) Gut Hormones: A Weight Off Your Mind. Journal of Neuroendocrinology 20:6, pages 834-841.
Crossref
Judith Korner, Marc Bessler, William Inabnet, Carmen Taveras & Jens Juul Holst. (2007) Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding. Surgery for Obesity and Related Diseases 3:6, pages 597-601.
Crossref
Jens Juul Holst. (2007) The Physiology of Glucagon-like Peptide 1. Physiological Reviews 87:4, pages 1409-1439.
Crossref
Katie Wynne & Stephen R Bloom. (2006) The role of oxyntomodulin and peptide tyrosine–tyrosine (PYY) in appetite control. Nature Clinical Practice Endocrinology & Metabolism 2:11, pages 612-620.
Crossref
Owais Chaudhri, Caroline Small & Steve Bloom. (2006) Gastrointestinal hormones regulating appetite. Philosophical Transactions of the Royal Society B: Biological Sciences 361:1471, pages 1187-1209.
Crossref
Patti J. ThureenJudith Sondheimer. 2009. Neonatal Nutrition and Metabolism. Neonatal Nutrition and Metabolism 492 507 .
M. S. B. Huda, J. P. H. Wilding & J. H. Pinkney. (2006) Gut peptides and the regulation of appetite. Obesity Reviews 7:2, pages 163-182.
Crossref
Maralyn Druce & Mohammad Ghatei. (2006) Oxyntomodulin. Current Opinion in Endocrinology and Diabetes 13:1, pages 49-55.
Crossref
Maralyn R Druce & Stephen R Bloom. (2006) Oxyntomodulin. Treatments in Endocrinology 5:5, pages 265-272.
Crossref
J B Bristol, M Wells & R C N Williamson. (1984) Adaptation to jejunoileal bypass promotes experimental colorectal carcinogenesis. British Journal of Surgery 71:2, pages 123-126.
Crossref
J Miskowiak & B Andersen. (1983) Intestinal adaptation after jejunoileal bypass for morbid obesity: A possible explanation for inadequate weight loss. British Journal of Surgery 70:1, pages 27-28.
Crossref
G R Sagor, M A Ghatei, G P McGregor, P Mitchenere, R M Kirk & S R Bloom. (1981) The influence of an intact pylorus on postprandial enteroglucagon and neurotensin release after upper gastric surgery. British Journal of Surgery 68:3, pages 190-193.
Crossref
Jason J. CislerAlan L. Buchman. (2023) Intestinal Adaptation in Short Bowel Syndrome. Journal of Investigative Medicine 53:8, pages 402-413.
Crossref
Sarah Stanley, Katie Wynne, Barbara McGowan & Stephen Bloom. (2005) Hormonal Regulation of Food Intake. Physiological Reviews 85:4, pages 1131-1158.
Crossref
Katie Wynne, Adrian J. Park, Caroline J. Small, Michael Patterson, Sandra M. Ellis, Kevin G. Murphy, Alison M. Wren, Gary S. Frost, Karim Meeran, Mohammad A. Ghatei & Stephen R. Bloom. (2005) Subcutaneous Oxyntomodulin Reduces Body Weight in Overweight and Obese Subjects. Diabetes 54:8, pages 2390-2395.
Crossref
Simon Aylwin. (2005) Gastrointestinal surgery and gut hormones. Current Opinion in Endocrinology & Diabetes 12:1, pages 89-98.
Crossref
Laurie L. Baggio, Qingling Huang, Theodore J. Brown & Daniel J. Drucker. (2004) Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure. Gastroenterology 127:2, pages 546-558.
Crossref
D.G. Burrin, B. Stoll & X. Guan. (2003) Glucagon-like peptide 2 function in domestic animals. Domestic Animal Endocrinology 24:2, pages 103-122.
Crossref
Palle Bekker Jeppesen & Per Brobech Mortensen. (2002) Enhancing bowel adaptation in short bowel syndrome. Current Gastroenterology Reports 4:4, pages 338-347.
Crossref
S-C. Chao & J.y-Y. Lee. (2002) Brittle nails and dyspareunia as first clues to recurrences of malignant glucagonoma. British Journal of Dermatology 146:6, pages 1071-1074.
Crossref
Daniel J. Drucker. (2002) Biological actions and therapeutic potential of the glucagon-like peptides. Gastroenterology 122:2, pages 531-544.
Crossref
K. Ljungmann, B. Hartmann, P. Kissmeyer-NielsenA. Flyvbjerg, J. J. Holst & S. Laurberg. (2001) Time-dependent intestinal adaptation and GLP-2 alterations after small bowel resection in rats. American Journal of Physiology-Gastrointestinal and Liver Physiology 281:3, pages G779-G785.
Crossref
C Verdich, S Toubro, B Buemann, J Lysgård Madsen, J Juul Holst & A Astrup. (2001) The role of postprandial releases of insulin and incretin hormones in meal-induced satiety—effect of obesity and weight reduction. International Journal of Obesity 25:8, pages 1206-1214.
Crossref
Kathryn A. Kollman, Olivier Goulet & Jon A. Vanderhoof. (2001) Saccharomyces boulardii Does Not Stimulate Mucosal Hyperplasia after Intestinal Resection in the Rat. Journal of Pediatric Gastroenterology and Nutrition 32:4, pages 454-457.
Crossref
Frank L. Greenway. (1996) SURGERY FOR OBESITY. Endocrinology and Metabolism Clinics of North America 25:4, pages 1005-1027.
Crossref
Kelly A. Tappenden, Alan B.R. Thomson, Gary E. Wild & Michael I. McBurney. (2016) Short-Chain Fatty Acids Increase Proglucagon and Ornithine Decarboxylase Messenger RNAs After Intestinal Resection in Rats. Journal of Parenteral and Enteral Nutrition 20:5, pages 357-362.
Crossref
Jon A. Vanderhoof. (1996) SHORT BOWEL SYNDROME IN CHILDREN AND SMALL INTESTINAL TRANSPLANTATION. Pediatric Clinics of North America 43:2, pages 533-550.
Crossref
Shohei Iijima, Toshimasa Tsujinaka, Masanori Kishibuchi, Yoshihiro Kido, Chikara Ebisui, Kazuomi Kan, Masahiko Yano & Takesada Mori. (1996) A Total Parenteral Nutrition Solution Supplemented with a Nucleoside and Nucleotide Mixture Sustains Intestinal Integrity, but Does Not Stimulate Intestinal Function after Massive Bowel Resection in Rats. The Journal of Nutrition 126:3, pages 589-595.
Crossref
N J Brown, R D Rumsey & N W Read. (1994) Gastrointestinal adaptation to enhanced small intestinal lipid exposure.. Gut 35:10, pages 1409-1412.
Crossref
Johannes Miholic, Catherine �rskov, Jens Juul Holst, Jochen Kotzerke & H. J. Meyer. (1991) Emptying of the gastric substitute, glucagon-like peptide-1 (GLP-1), and reactive hypoglycemia after total gastrectomy. Digestive Diseases and Sciences 36:10, pages 1361-1370.
Crossref
Dominique Bataille. 2011. Comprehensive Physiology. Comprehensive Physiology 455 474 .
Jens Juul Holst. 1988. Gastrointestinal Hormones. Gastrointestinal Hormones 393 419 .
S.R. Bloom & J.M. Polak. 1988. Gastrointestinal Hormones. Gastrointestinal Hormones 69 83 .
James B. Bristol, Mohammed A. Ghatei, John H.F. Smith, Stephen R. Bloom & Robin C.N. Williamson. (1987) Elevated plasma enteroglucagon alone fails to alter distal colonic carcinogenesis in rats. Gastroenterology 92:3, pages 617-624.
Crossref
A P Savage, G E Gornacz, T E Adrian, M A Ghatei, R A Goodlad, N A Wright & S R Bloom. (1985) Is raised plasma peptide YY after intestinal resection in the rat responsible for the trophic response?. Gut 26:12, pages 1353-1358.
Crossref
James B. Bristol & Robin C. N. Williamson. (1985) Postoperative adaptation of the small intestine. World Journal of Surgery 9:6, pages 825-832.
Crossref
Norman W. Weisbrodt, Paul R. Nemeth, Rebecca L. Bowers & William A. Weems. (1985) Functional and Structural Changes in Intestinal Smooth Muscle After Jejunoileal Bypass in Rats. Gastroenterology 88:4, pages 958-963.
Crossref
G R Sagor, M A Ghatei, D J O'Shaughnessy, M Y Al-Mukhtar, N A Wright & S R Bloom. (1985) Influence of somatostatin and bombesin on plasma enteroglucagon and cell proliferation after intestinal resection in the rat.. Gut 26:1, pages 89-94.
Crossref
A F Kilander, G Dotevall, G Lindstedt & P A Lundberg. (1984) Plasma enteroglucagon related to malabsorption in coeliac disease.. Gut 25:6, pages 629-635.
Crossref
Donald P. Kotler & Henry Koopmans. (1984) Preservation of intestinal structure and function despite weight loss produced by ileal transposition in rats. Physiology & Behavior 32:3, pages 423-427.
Crossref
N.W. Read, A. McFarlane, R.I. Kinsman, T.E. Bates, N.W. Blackhall, G.B.J. Farrar, J.C. Hall, G. Moss, A.P. Morris, B. O'Neill, I. Welch, Y. Lee & S.R. Bloom. (1984) Effect of infusion of nutrient solutions into the ileum on gastrointestinal transit and plasma levels of neurotensin and enteroglucagon. Gastroenterology 86:2, pages 274-280.
Crossref
N. W. Read, A. McFarlane, R. I. Kinsman & S. R. Bloom. 1983. Gastrointestinal Motility. Gastrointestinal Motility 335 342 .
Jens J. Holst. (1983) Gut glucagon, enteroglucagon, gut glucagonlike immunoreactivity, glicentin—Current status. Gastroenterology 84:6, pages 1602-1613.
Crossref
G.R. Sagor, M.A. Ghatei, M.Y.T. Al-Mukhtar, N.A. Wright & S.R. Bloom. (1983) Evidence for a humoral mechanism after small intestinal resection. Gastroenterology 84:5, pages 902-906.
Crossref
J. J. Holst. 1983. Glucagon II. Glucagon II 507 521 .
A. J. Moody & L. Thim. 1983. Glucagon I. Glucagon I 139 174 .
Agneta Kulneff-Herlin, Per Herlin, Mei-Huei Chen, Zwi Gimmon, Richard F. Murphy & Stephen N. Joffe. (1982) Circulating immunoreactivities of gastrin, glucagon and VIP after jejuno-ileal bypass. Peptides 3:1, pages 91-93.
Crossref
Lucien R. Jacobs, Stephen R. Bloom & R.Hermon Dowling. (1981) Response of plasma and tissue levels of enteroglucagon immunoreactivity to intestinal resection, lactation and hyperphagia. Life Sciences 29:19, pages 2003-2007.
Crossref
A.J. MOODY. (1980) Gut Glucagon-like Immunoreactants. Clinics in Gastroenterology 9:3, pages 699-709.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.